SpaceX IPO: Derivatives signaled price; tokenized access failed
SpaceX’s June 12 IPO raised $75 billion at $135 per share, valuing it above $2 trillion. Crypto derivatives signaled the price; tokenized IPO campaigns were canceled and subscribers received no shares.
SpaceX priced its June 12 IPO at $135 per share, raising $75 billion and valuing the company above $2 trillion. Ahead of the Nasdaq opening, crypto derivatives markets provided live price signals while several tokenized IPO subscription campaigns were later canceled and subscribers were refunded without receiving shares.
Talos Research data shows SPCX perpetual futures reached a volume-weighted average price of $159.89 in the 30 minutes before the Nasdaq open across Hyperliquid, Binance and OKX, about 6.6% above the opening print. Perpetuals had peaked above $220 in mid-May and converged lower as the IPO date approached. On the day of the listing, SPCX perpetuals recorded roughly $4.6 billion in trading volume and total open interest peaked near $500 million across eight platforms.
Exchanges and wallet providers organized tokenized access through third-party distribution arrangements tied to primary-market allocations. Platforms including Binance, Bybit and Bitget Wallet canceled subscription campaigns after issuers and intermediaries were unable to obtain sufficient IPO shares from underwriters. Platforms returned funds to subscribers rather than delivering underlying stock allocations.
Binance founder Changpeng Zhao posted on X: “Protect users when things don’t go as planned,” after the exchange issued cancellation notices. Users reported about $557 million was raised across three exchanges for tokenized SpaceX access and that the campaigns ultimately returned no shares.
Bitget said customers had subscribed through a Kraken xStocks initiative and that the tokenized claims, “if issued,” would have represented economic exposure to SpaceX shares. Those tokens were not delivered. Bitget canceled pre-market subscriptions, refunded users and announced it would offer broker-backed 1:1 tokenized SpaceX shares on a platform called Reality, with the tokens held by a broker.
Market participants drew a distinction between price formation on derivatives venues and the mechanics of allocating primary IPO shares. Talos Research’s Samar Sen described pre-IPO perpetuals as having “functioned as intended,” noting they provided continuous trading and price discovery before the listing. Talos said such markets could provide an additional input alongside institutional orders and private-market marks for high-profile listings.
Legal advisers cautioned that a token sold to raise sums on the scale of SpaceX’s IPO would be treated as a security and face registration, tax and regulatory review. A 2026 staff statement from securities regulators reiterated that tokenized stocks are securities subject to registration and disclosure requirements and distinguished custodial, issuer-sponsored tokenization from synthetic third-party wrappers.
Tokenization advocates reported that onchain distribution and settlement infrastructure can operate continuously but that primary allocations remain controlled by underwriters and broker-dealers. Dinari’s chief executive Gabriel Otte noted his platform’s tokenized SPCX stayed online during the allocation failures and said tokenization should rely on regulated custody and clear legal rights for underlying shares.
The listing combined active derivatives trading with cancelled tokenized stock campaigns. Exchanges, platform operators and tokenization proponents indicated that offering tokenized equity products tied to actual share allocations will require deeper cooperation with broker-dealers and regulators.
The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.







